Optical Coherence Tomography Angiography in Glaucoma: A Review
Glaucoma is the leading cause of irreversible blindness worldwide. Several techniques exist for the diagnosis and follow-up of patients. Optical coherence tomography (OCT) angiography (OCTA) is a recently developed technique that provides a quantitative assessment of the microcirculation of the reti...
Saved in:
Published in | Ophthalmic research Vol. 60; no. 3; p. 139 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
01.01.2018
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Abstract | Glaucoma is the leading cause of irreversible blindness worldwide. Several techniques exist for the diagnosis and follow-up of patients. Optical coherence tomography (OCT) angiography (OCTA) is a recently developed technique that provides a quantitative assessment of the microcirculation of the retina and choroid in a fast, noninvasive way. Despite it being a novel technique, several publications have already been done in the glaucoma field. However, a summary of findings is currently lacking.
To perform a literature review to assess the role of OCTA in glaucoma diagnosis and follow-up.
A database search was carried out using MEDLINE, Embase, and Web of Science, including all original works registered until July 23, 2017.
OCTA (1) has a high repeatability and reproducibility, (2) has good discriminatory power to differentiate normal eyes from glaucoma eyes, (3) is more strongly correlated with visual function than conventional OCT, (4) has good discriminatory power to differentiate early-glaucoma eyes from normal eyes (i.e., at least equal to that of OCT), (5) reaches a floor effect at a more advanced disease stage than OCT, and (6) is able to detect progression in glaucoma eyes.
OCTA shows potential to become a part of everyday glaucoma management. |
---|---|
AbstractList | Glaucoma is the leading cause of irreversible blindness worldwide. Several techniques exist for the diagnosis and follow-up of patients. Optical coherence tomography (OCT) angiography (OCTA) is a recently developed technique that provides a quantitative assessment of the microcirculation of the retina and choroid in a fast, noninvasive way. Despite it being a novel technique, several publications have already been done in the glaucoma field. However, a summary of findings is currently lacking.
To perform a literature review to assess the role of OCTA in glaucoma diagnosis and follow-up.
A database search was carried out using MEDLINE, Embase, and Web of Science, including all original works registered until July 23, 2017.
OCTA (1) has a high repeatability and reproducibility, (2) has good discriminatory power to differentiate normal eyes from glaucoma eyes, (3) is more strongly correlated with visual function than conventional OCT, (4) has good discriminatory power to differentiate early-glaucoma eyes from normal eyes (i.e., at least equal to that of OCT), (5) reaches a floor effect at a more advanced disease stage than OCT, and (6) is able to detect progression in glaucoma eyes.
OCTA shows potential to become a part of everyday glaucoma management. |
Author | Huygens, Marc Barbosa-Breda, João Van Melkebeke, Lukas Stalmans, Ingeborg |
Author_xml | – sequence: 1 givenname: Lukas surname: Van Melkebeke fullname: Van Melkebeke, Lukas – sequence: 2 givenname: João surname: Barbosa-Breda fullname: Barbosa-Breda, João – sequence: 3 givenname: Marc surname: Huygens fullname: Huygens, Marc – sequence: 4 givenname: Ingeborg surname: Stalmans fullname: Stalmans, Ingeborg |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29794471$$D View this record in MEDLINE/PubMed |
BookMark | eNo1j81Kw0AURgdR7I8ufAGZF4jemdxkMi6EEGoVCgWp63JnctOO5I-kVfr2CtrVdxaHA99MXLZdy0LcKXhQKrGPAIBZhja5EFOFOo5AJ3YiZuP4CfArWLgWE22NRTRqKp7X_SF4qmXR7Xng1rPcdE23G6jfn2Te7sKZQyuXNR1919CTzOU7fwX-vhFXFdUj3_7vXHy8LDbFa7RaL9-KfBV5BDhEziobs-XYaFRZZrBKE624pFR5Mqkm4pTRpOitcY5KnVUJxFo5cqiBKz0X93_d_ugaLrf9EBoaTtvzEf0DhC9IGg |
CitedBy_id | crossref_primary_10_1080_17469899_2022_2101449 crossref_primary_10_3389_fneur_2020_604049 crossref_primary_10_1177_11206721211063716 crossref_primary_10_4103_ijo_IJO_84_22 crossref_primary_10_1007_s00417_020_04934_y crossref_primary_10_1016_j_pdpdt_2021_102611 crossref_primary_10_53432_2078_4104_2024_23_3_45_53 crossref_primary_10_3390_jcm14051587 crossref_primary_10_1016_j_preteyeres_2022_101160 crossref_primary_10_1007_s10792_022_02239_z crossref_primary_10_1016_j_oftale_2023_09_004 crossref_primary_10_3390_jcm12123936 crossref_primary_10_3390_jcm12165335 crossref_primary_10_3389_fmed_2022_1037471 crossref_primary_10_2174_1573405617666210412141244 crossref_primary_10_1038_s41598_023_44053_2 crossref_primary_10_1080_08164622_2023_2259390 crossref_primary_10_1007_s10103_023_03907_x crossref_primary_10_3389_fopht_2022_1057896 crossref_primary_10_1111_ceo_13755 crossref_primary_10_4103_erj_erj_7_21 crossref_primary_10_1111_aos_14392 crossref_primary_10_3389_fmed_2023_1150295 crossref_primary_10_1007_s10792_024_03237_z crossref_primary_10_1109_JSEN_2024_3439748 crossref_primary_10_1016_j_preteyeres_2020_100841 crossref_primary_10_3390_biomedicines13020318 crossref_primary_10_1016_j_oftale_2023_04_002 crossref_primary_10_1080_02713683_2020_1849728 crossref_primary_10_1016_j_oftal_2023_09_006 crossref_primary_10_1111_aos_14385 crossref_primary_10_1159_000520030 crossref_primary_10_18008_1816_5095_2020_3_336_343 crossref_primary_10_1016_j_ajo_2021_05_016 crossref_primary_10_12688_f1000research_140453_1 crossref_primary_10_1016_j_ajo_2021_05_019 crossref_primary_10_1016_j_ajo_2021_11_008 crossref_primary_10_1080_02713683_2020_1801756 crossref_primary_10_1167_tvst_9_2_58 crossref_primary_10_1016_j_oftal_2023_04_005 crossref_primary_10_1097_IJG_0000000000001578 crossref_primary_10_1167_tvst_11_7_15 crossref_primary_10_1097_IJG_0000000000001859 crossref_primary_10_1021_acsanm_1c03640 crossref_primary_10_1080_02648725_2023_2218765 crossref_primary_10_1111_vop_12973 crossref_primary_10_1159_000494041 crossref_primary_10_1136_bjophthalmol_2020_317181 crossref_primary_10_2147_OPTH_S472231 crossref_primary_10_1111_opo_13448 crossref_primary_10_1364_OE_504877 crossref_primary_10_1016_j_jocn_2022_04_012 crossref_primary_10_1111_aos_14805 crossref_primary_10_1155_2021_5588077 crossref_primary_10_1159_000517097 crossref_primary_10_1155_2021_9916102 crossref_primary_10_1007_s11357_021_00492_1 crossref_primary_10_1080_08820538_2020_1845386 crossref_primary_10_1016_j_pdpdt_2024_104444 crossref_primary_10_1016_j_yaoo_2021_04_002 crossref_primary_10_1117_1_OE_59_6_061624 crossref_primary_10_3390_app11209734 crossref_primary_10_1167_tvst_9_12_7 crossref_primary_10_53432_2078_4104_2021_20_2_3_13 crossref_primary_10_1155_2020_7361492 crossref_primary_10_3390_jcm12154899 crossref_primary_10_3390_ijms22094662 crossref_primary_10_1016_j_ogla_2025_02_005 crossref_primary_10_1136_bjophthalmol_2020_318166 crossref_primary_10_1364_OL_520840 crossref_primary_10_4103_ejos_ejos_2_22 crossref_primary_10_1001_jamaophthalmol_2019_0422 crossref_primary_10_1167_iovs_61_14_33 crossref_primary_10_1136_bjophthalmol_2018_313461 crossref_primary_10_18663_tjcl_1308157 crossref_primary_10_1097_IJG_0000000000001828 crossref_primary_10_1007_s10384_019_00691_6 crossref_primary_10_3390_jcm10204785 crossref_primary_10_1016_j_oftale_2023_05_004 crossref_primary_10_3389_fbioe_2024_1329263 crossref_primary_10_1155_2022_6182592 crossref_primary_10_3389_fmed_2023_1169504 crossref_primary_10_4103_tjo_TJO_D_24_00044 crossref_primary_10_1186_s12886_020_01701_9 crossref_primary_10_3390_scipharm89030040 crossref_primary_10_1177_1120672120967233 crossref_primary_10_3390_jcm10235490 crossref_primary_10_1016_j_survophthal_2024_11_009 crossref_primary_10_1159_000526850 crossref_primary_10_1167_tvst_9_7_34 crossref_primary_10_1016_j_ophtha_2019_12_030 crossref_primary_10_1038_s41598_023_40025_8 crossref_primary_10_1007_s10792_024_03221_7 crossref_primary_10_2147_OPTH_S429718 crossref_primary_10_1159_000509954 crossref_primary_10_1007_s10792_021_02005_7 crossref_primary_10_1111_cxo_12854 crossref_primary_10_1007_s00417_021_05367_x crossref_primary_10_2298_VSP200526084P crossref_primary_10_1177_1120672120946545 crossref_primary_10_12677_HJO_2023_121004 crossref_primary_10_1016_j_oftal_2023_01_011 crossref_primary_10_1007_s10792_022_02574_1 crossref_primary_10_1016_j_aopr_2022_100036 crossref_primary_10_3389_fmed_2022_999167 crossref_primary_10_1097_IJG_0000000000002069 crossref_primary_10_1080_08164622_2024_2306963 crossref_primary_10_1111_aos_14696 crossref_primary_10_1111_aos_14851 crossref_primary_10_3389_fnagi_2021_747050 |
ContentType | Journal Article |
Copyright | 2018 S. Karger AG, Basel. |
Copyright_xml | – notice: 2018 S. Karger AG, Basel. |
DBID | NPM |
DOI | 10.1159/000488495 |
DatabaseName | PubMed |
DatabaseTitle | PubMed |
DatabaseTitleList | PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1423-0259 |
ExternalDocumentID | 29794471 |
Genre | Journal Article |
GroupedDBID | --- .GJ 0~5 0~B 123 29N 30W 329 34G 39C 3O- 3O. 3V. 4.4 53G 5RE 7X7 88E 8AO 8FI 8FJ 8FW 8UI AALGM AAYIC ABBTS ABJNI ABPAZ ABUWG ABWCG ACGFS ACNCT ACPRK ACPSR ACQXL ADAGL ADBBV AENEX AEYAO AFJJK AFKRA AFRAH AFSIO AHFRZ AHMBA ALDHI ALIPV ALMA_UNASSIGNED_HOLDINGS AZPMC BENPR BPHCQ BVXVI CAG CCPQU COF CS3 CYUIP DU5 E0A EBS EJD EMOBN F5P FB. FYUFA GROUPED_DOAJ HMCUK HZ~ IAO IHR INH ITC IY7 KUZGX M-- M1P N9A NPM O1H O9- OK1 PQQKQ PROAC PSQYO RIG RKO RXVBD UJ6 UKHRP WH7 ZGI ZXP |
ID | FETCH-LOGICAL-c400t-b9193e9e372418874f6521eda61ca762aae6e4764c97bbad28f50321bab420ef2 |
IngestDate | Wed Feb 19 02:43:01 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | Glaucoma Diagnosis Optical coherence tomography angiography Ocular blood flow |
Language | English |
License | 2018 S. Karger AG, Basel. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c400t-b9193e9e372418874f6521eda61ca762aae6e4764c97bbad28f50321bab420ef2 |
PMID | 29794471 |
ParticipantIDs | pubmed_primary_29794471 |
PublicationCentury | 2000 |
PublicationDate | 2018-01-01 |
PublicationDateYYYYMMDD | 2018-01-01 |
PublicationDate_xml | – month: 01 year: 2018 text: 2018-01-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland |
PublicationTitle | Ophthalmic research |
PublicationTitleAlternate | Ophthalmic Res |
PublicationYear | 2018 |
SSID | ssj0015990 |
Score | 2.4845724 |
SecondaryResourceType | review_article |
Snippet | Glaucoma is the leading cause of irreversible blindness worldwide. Several techniques exist for the diagnosis and follow-up of patients. Optical coherence... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 139 |
Title | Optical Coherence Tomography Angiography in Glaucoma: A Review |
URI | https://www.ncbi.nlm.nih.gov/pubmed/29794471 |
Volume | 60 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1JS8QwFA4uIF7EfZccvEm0S7rEgzCKMoqjlxG8DUmazIzjtIOOB_31vjbptLihXkpoaGj6fX15eXkLQvua80glmhERU05g_0WJ4H5CHOl6MtaeE-jcDtm6CZt39Oo-uK_ciorokrE4lG9fxpX8B1W4B7jmUbJ_QHYyKNyANuALV0AYrr_C-HZkLNF5jIXJFtvOhjYH9UEj7fbLdj9PncFf4B24CUWvHQk8lGP1xj3-OCxSOtdMXKYY10FLPQ4ACePKc_0y4JV5nT-J7JmT0yeVGMfbrDh997OKMq8whWcbGiQnRh3Q-4dWj79Mu7ng69aNEG5cM0IoIzhBLSOgP7G6ZDWVAiyD_JqYdE0Co8_iO2DG3xHECjXFN2swjoYFjh4DGUJN4Zafez9k0i67ptE07CnyIqm5ZceeOAWwLNvMU9A-mrxDni3aPvdh51FoIO1FtGC3DrhheLCEplS6jOZa1jliBZ1YOuAJHXBFB1yjA-6nuKTDMW5gQ4ZVdHdx3j5rElseg0gQvGMiGCjfiik_Ai0M1gqqQ9DFAOrQlRzWOM5VqGgUUskiIXjixTpwfM8VXFDPUdpbQzNplqoNhJXSTiIdX3owFg1jlrhhwmgCo6iISr2J1s3MOyOTA6VTfpOtb3u20XzFlB00q-GnU7ugwY3FXvHp3wEH5kTP |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Optical+Coherence+Tomography+Angiography+in+Glaucoma%3A+A+Review&rft.jtitle=Ophthalmic+research&rft.au=Van+Melkebeke%2C+Lukas&rft.au=Barbosa-Breda%2C+Jo%C3%A3o&rft.au=Huygens%2C+Marc&rft.au=Stalmans%2C+Ingeborg&rft.date=2018-01-01&rft.eissn=1423-0259&rft.volume=60&rft.issue=3&rft.spage=139&rft_id=info:doi/10.1159%2F000488495&rft_id=info%3Apmid%2F29794471&rft_id=info%3Apmid%2F29794471&rft.externalDocID=29794471 |